Continuity of Cancer Treatment Amidst the 2026 Gulf Regional Conflict: Insights and a Resilience Model from Gulf States - Summary - MDSpire

Continuity of Cancer Treatment Amidst the 2026 Gulf Regional Conflict: Insights and a Resilience Model from Gulf States

  • By

  • Humaid O. Al-Shamsi

  • Saeed Rafii

  • Maha Al Sindi

  • Ahmad Alhuraiji

  • Nedal Bukhari

  • Ibrahim Abu-Gheida

  • Deborah Mukherji

  • April 23, 2026

  • 0 min

Share

Objective:

To examine how continuity of cancer care was maintained in Gulf states during the 2026 regional conflict and identify specific resilience factors in oncology services.

Key Findings:
  • Oncology services in the UAE, Bahrain, Kuwait, and Saudi Arabia operated with minimal disruption during the conflict, showcasing effective crisis management.
  • Key resilience factors included advanced healthcare infrastructure and robust pharmaceutical supply chains, which were crucial for uninterrupted service.
  • Public trust in healthcare institutions and strong governance were pivotal in maintaining high-quality cancer care during the crisis.
Interpretation:

The findings suggest that resilience in oncology care extends beyond mere survival of healthcare systems; it encompasses the ability to deliver uninterrupted, high-quality cancer treatment even in prolonged crises, highlighting the need for strategic planning.

Limitations:
  • Absence of contributions from Oman and Qatar limits the comprehensiveness of the analysis, potentially overlooking regional dynamics.
  • Focus on only four GCC countries may not fully represent the regional dynamics, suggesting a need for broader studies.
Conclusion:

Understanding the factors that enabled continuity of cancer care during the Gulf conflict provides valuable lessons for enhancing health system preparedness against geopolitical instability and ensuring resilience in healthcare delivery.

Original Source(s)

Related Content